Crowdonomics
All companies
LUWI logo

LUWI

Operating

Let Us Wear It Inc. (LUWI)

Healthcare · Mt Prospect, IL · Founded 2024

Where protection meets pleasure

Post-money valuation ⓘ
$25.1M
As of Oct 2024 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$62,157
Across 1 round since 2024
Latest share price
$1.00
Reg CF · Common Stock · Jul 2024 offering price

Financials

FY2022–FY2025 · from SEC filings · hover any figure for its source
$0
−$65K
2022
$0
−$156K
2023
$0
−$497K
2024
$794
−$520K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 reviewed
FY2023 reviewed
FY2024
FY2025
Income statement
Revenue
$0
$0
$0
$794
Cost of goods sold
$0
$0
$0
$0
Gross margin
—
—
—
100%
Net income
-$65,001
-$156,345
-$497,177
-$520,110
Taxes paid
$0
$0
$12,129
$14,084
Balance sheet
Cash
$40,716
$180,534
$102,796
$522,217
Accounts receivable
$0
$0
$0
$0
Total assets
$40,716
$279,288
$270,781
$843,606
Short-term debt
$27,352
$32,268
$14,034
$22,170
Long-term debt
$0
$0
$0
$0
Total liabilities
$27,352
$32,268
$14,034
$22,170
Other
Headcount
—
2
—
2

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$25.0M
pre-money
Reg CF · Common · Jul 2024

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Raised $62.2K / $1.2MInvestors 81Post-money $25.1M

Team

19 people
Lisa KinsellaFounder
Founder, CEO & Director

Lisa Kinsella, CEO of LUWI, is a seasoned sales executive turned entrepreneur. Her journey began from a personal need for hormone-free contraception options. With a background in tech sales and experiences like commercial fishing in Alaska and reaching Mount Everest's base camp, Lisa combines grit and industry expertise. She holds a BA from Marquette University and a Certificate of Management from the University of Chicago, Booth School of Business. Lisa will be providing Form C sign-off as the Company's Principal Accounting Officer.

Lisa Marie KinsellaFounder
Founder, CEO and Director
Leslie Gall
Director, COO (part-time)

Leslie Gall is an experienced operations executive with over 20 years at Fortune 500 companies, specializing in global marketing, brand repositioning, and digital transformation. She founded Kanken Marketing Group LLC, a firm focused on strategic planning and brand management. Previously, she held CMO roles at Alight Solutions, CBRE, and JLL. Leslie advises Grand Champion Meats and holds a Bachelor of Social Science from Mundelein College and an MBA from DePaul University Kellstadt School of Business. Leslie currently services 10-20 hours per week in their role with the Issuer.

Leslie Marie Gall
COO, Director and principal accounting officer
Jeff Garlow
Head of Sales

Jeff Garlow is a seasoned professional with over 24 years of experience in the sexual healthcare industry, specializing in retail and public sector sales. Jeff has held various leadership roles in the healthcare sector, consistently exceeding sales targets and playing a significant role in the overall success of the organizations he has worked with. Equipped with an MBA degree, Jeff possesses a strong business acumen that enables him to identify and capitalize on new opportunities within the sexual health industry. His strategic thinking and analytical skills have been instrumental in developing effective sales and marketing campaigns, as well as forging successful partnerships and collaborations. Throughout his career, Jeff has remained at the forefront of industry trends and emerging technologies, enabling him to stay ahead of the competition. He is known for his ability to adapt to changing market dynamics and implement innovative solutions that drive business growth. Jeff is part-time and works 10 hours on LUWI a week.

Cat Gallagher
Regulatory Lead

Cat is the Principal of the Gallagher Mailhot Law Group, a boutique law practice serving the FDA regulated product industry.

Danielle McWaters
Creative Director

Danielle McWaters is an award-winning designer with extensive experience in photography , graphic design, and brand strategy design. She is an expert in CPG packaging and global marketing campaigns and the Founder of Designsake Studio. Danielle is a believer of design and its ability to create new connections and lasting impressions authentically. Danielle is part time and works on LUWI 10 hours per week.

Dr. Lauren Streicher, MD
Physician in Residence

Lauren Streicher, MD, is a clinical professor of Obstetrics and Gynecology at Northwestern University, and founding Medical Director of the Northwestern Medicine Center for Sexual Medicine and Menopause. She is a certified menopause practitioner, Senior Research Fellow at the Kinsey Institute, and director at Midi Health. A best-selling author and media contributor, she also hosts the "Inside Information Podcast."

Marissa Freeman Eanet
Brand Strategist

Based in Chicago, Marissa is a Brand and Marketing Strategist with 15+ years experience across CPG, DTC Ecommerce, women’s leadership, non-profit, and fitness community marketing. Marissa is a Bar Method fitness instructor and founder of The Village, an online coworking space for “solopreneurial” women.

Show 10 more people
Sam Feingold
Educator and Campus Growth Manager

Sam Feingold, LUWI Product Educator and Campus Growth Manager, holds a B.S. in Biology and a minor in Ethics from Emory University. With both clinical and commercial experience in reproductive health, she is passionate about health literacy and health equity, working to bring innovative STI-preventing contraceptive options to campuses nationwide.

Alyssa Rapp
Advisor

CEO of Empower Aesthetics and lecturer at Stanford and University of Chicago Booth, Alyssa founded Bottlenotes, Inc. and authored "Leadership and Life Hacks." She has led successful turnarounds, serves on several boards, and holds a BA from Yale and an MBA from Stanford. Her diverse roles span health, wellness, and corporate leadership.

Carl Stern
Advisor

Partner at Lunch Partners and Advisor at ICI Fund, Carl Stern formerly served as vice-chairman of Goldman Sachs' Investment Banking Division and CEO of Boston Consulting Group. He advises global companies like PepsiCo and GE, serves on several boards, and holds a BA from Harvard and an MBA from Stanford.

Dr. Ina Park, MD MS
Advisor

Associate Professor at UCSF and Medical Director of the California Prevention Training Center, Dr. Ina Park consults for the CDC and authored "Strange Bedfellows." She focuses on reducing STI stigma and improving sexual health, with a career beginning as a peer educator at UC Berkeley and advanced training at UCLA and UCSF.

Dr. Laurie Mintz, PHD
Advisor

Emeritus Professor at the University of Florida, Dr. Laurie Mintz is an author, therapist, and speaker focused on enhancing sexual satisfaction. She authored "Becoming Cliterate" and "A Tired Woman’s Guide to Passionate Sex," and has a TEDx talk with over two million views. She is a Fellow of the APA and Forbes “50 over 50” innovator.

Dr. Mary Lake Polan, MD, PHD, MPH
Advisor

Professor at Stanford, Dr. Mary Lake Polan combines rigorous research with clinical expertise in women's health. She earned her PhD and MD from Yale, and MPH from UC Berkeley. With over 130 publications, she has led surgical missions to East Africa and served on NIH committees, focusing on reproductive endocrinology.

Rachel Braun Scherl
Advisor

Growth Strategist and women's health expert, Rachel co-founded SPARK and Semprae Laboratories, and authored "Orgasmic Leadership." Recognized by NJBiz and SmartCEO, she holds an MBA from Stanford and leads global engagements with firms like Johnson & Johnson and Pfizer. She is a sought-after speaker and consultant.

Seth Mailhot
Advisor

Partner and FDA Group Leader, Seth advises on FDA compliance across food, medical devices, and drugs. With a background in chemical engineering and extensive FDA experience, he supports clients in premarket strategies, postmarket compliance, and corporate transactions, covering emerging markets like ENDS and cannabidiol.

Trish Lukasik
Advisor

An executive with over 25 years of strategic leadership at Procter & Gamble, Coca-Cola, and PepsiCo, Trish now works with tech start-ups, venture capital, and private equity. She serves on corporate boards including Sargento Foods and Gorilla Glue and is a Henry Crown Fellow of the Aspen Institute. She holds an MBA from Emory University.

William Vignocchi
Advisor

William Vignocchi is a distinguished leader in the heavy civil construction industry, heading a PBE-certified company by the Illinois Department of Central Management Services. He expanded his firm's impact to the public health sector as a leading condom distributor for public clients, promoting safe sex practices. Vignocchi holds influential roles, including Treasurer of the Mid America Regional Bargaining Association and Board Member of the Chicagoland Laborers District Council Training and Apprenticeship Fund.

Names and titles as disclosed on StartEngine, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 2 annual reports (FY2024–FY2025)

81 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARMay 28, 20260002027807-26-000003
    EDGAR
  • Form C-UOct 28, 20240001665160-24-001477
    EDGAR
  • Form CJul 8, 20240001665160-24-001056
    EDGAR
Source: ManualCIK 0002027807DEShare price $1.00

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.